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Purpose
Classical studies of consanguinity have taken advantage of the relationship between
the gene frequency for a rare autosomal recessive disorder (q) and the proportion of
offspring of consanguineous couples who are affected with the same disorder. The
Swedish geneticist Gunnar Dahlberg provided the first theoretical formulation of the
inverse correlation between q and the increase in frequency of consanguineous
marriages among parents of affected children with respect to marriages of the same
degree in the general population. Today it is possible to develop a new approach for
estimating q using mutation analysis of affected offspring of consanguineous couples.
The rationale of this new approach is based on the possibility that the child born of
consanguineous parents carries the same mutation in double copy (true homozygosity)
or alternatively carries two different mutations in the same gene (compound
heterozygosity). In the latter case the two mutations must have been inherited through
two different ancestors of the consanguineous parents (in this case the two mutated
alleles are not ‘identical by descent’).
Patients and methods
Data from the offspring of consanguineous marriages affected with different autosomal
recessive disorders were collected by different molecular diagnostic laboratories in
Mediterranean countries and in particular in Arab countries, where the frequencies of
consanguineous marriages is high, show the validity of this approach.
Results
The proportion of compound heterozygotes among children affected with a given
autosomal recessive disorder, born of consanguineous parents, can be taken as an
indirect indicator of the frequency of the same disorder in the general population.
Identification of the responsible gene (and mutations) is the necessary condition to
apply this method.
Conclusion
The following paper from our group relevant for the present review is being
published: Alessandro Gialluisi, Tommaso Pippucci, Yair Anikster, Ugur Ozbek, Myrna
Medlej-Hashim, Andre Megarbane and Giovanni Romeo: Estimating the allele
frequency of autosomal recessive disorders through mutational records and
consanguinity: the homozygosity index (HI) annals of human genetics (in press;
acceptance date 1 November 2011) In addition, our experimental data show that the
causative mutation for a rare autosomal recessive disorder can be identified by whole
exome sequencing of only two affected children of first cousins parents, as described
in the following recent paper: Pippucci T, Benelli M, Magi A, Martelli PL, Magini P,
Torricelli F, Casadio R, Seri M, Romeo G EX-HOM (EXome HOMozygosity): A Proof of
Principle. Hum Hered 2011; 72:45-53.
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The past approaches based on genetic
epidemiology
Classical studies of consanguinity have taken advantage of
the relationship between the frequency of a given
autosomal recessive disorder and the proportion of
offspring of consanguineous couples who are affected
with the same disorder. The Swedish geneticist Gunnar
Dahlberg provided the first theoretical formulation of the
inverse correlation between the gene frequency for rare
autosomal recessive disorders and the increase in
frequency of consanguineous marriages among parents
of affected children with respect to marriages of the same
degree in the general population. This approach allows
calculating the frequency of autosomal recessive disorders
in an unbiased way that is free of the problems arising
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from incomplete ascertainment. Complete ascertainment
means a complete survey of all individuals affected with a
given disorder, which is practically impossible in most
populations, especially those of developing countries.
Therefore, the three parameters that have been taken
into account in classical consanguinity studies are: (a) the
frequency of consanguineous parents of a given degree
(e.g. first cousins) among children with a specific
autosomal recessive disorder (C0); (b) the frequency of
consanguineous couples of the same degree in the general
population (C); and (c) the gene frequency (q) and
consequently the frequency in the population of that
specific autosomal recessive disorder (q2). If one knows
two of these parameters it is possible to calculate the
third one using mathematical formulas like the one used
by Dahlberg and by other population geneticists. In
particular, if one knows the first two parameters for any
specific population (C0 and C), it is possible to calculate
the frequency in the population of any given autosomal
recessive disorder, as done in the past in Italy for
phenylketonuria, Friedreich ataxia, and cystic fibrosis
(CF) (Romeo et al., 1983a, 1983b, 1985; Romeo, 1984).
The problem encountered by this type of genetic
epidemiology study based on consanguinity is represented
by the difficulty in having a precise and reliable estimate of
the second parameter mentioned above (C), namely, the
frequency in the general population of consanguineous
couples for any given degree (irrespective of their being
parents of an affected child). In Italy, this estimate was
possible up to 1964 because of the availability in Rome of
centralized Church archives that kept records of all the
dispensations (or permits to marry in Church) granted by
the Pope for consanguineous marriages for almost 400
years. These data were collected and organized for genetic
studies in 1960 by Cavalli-Sforza and co-workers (Cavalli-
Sforza et al., 2004). The absence of equivalent centralized
reliable data to calculate this parameter (C) has made it
impossible to use this approach in any other country.
The present approaches based on mutation
analysis
At present, it is possible to develop a new approach for
estimating the relative frequency of autosomal recessive
disorders using mutation data originated by the molecular
genetic centers that have diagnosed the affected off-
spring of consanguineous couples. The rationale of this
new approach, never experimented before, is based on
the possibility that the child born of consanguineous
parents carries the same mutation in double copy (true
homozygosity) or alternatively carries two different
mutations in the same gene (compound heterozygosity).
In the latter case, the two mutations must have been
inherited through two different ancestors of the con-
sanguineous parents (in this case, the two mutated alleles
are not ‘identical by descent’).
The allelic frequency of the pathogenic alleles in the
population (q) is therefore independent of consanguinity
and can be taken as an indirect indicator of the frequency
of the same disorder in the general population (irrespec-
tive of consanguinity). If the disease is rare, the
proportion of affected children born of consanguineous
parents who are true homozygotes (C0true-hom) should
be more relevant with respect to that of compound
heterozygotes (C0comp-het). This relationship can be
measured by the ratio (C0true-hom)/(C0true-hom)+
(C0comp-het), which will vary between 0 and 1 and will
take values inversely proportional to the frequency of the
disorder. We call this ratio ‘total homozygosity index’
(THI). We confirmed this hypothesis in two different
mutation data sets [for CF and familial Mediterranean
fever (FMF)] collected in Lebanon by Dr Andre´
Megabarne´ (Saint Joseph University, Beirut), and higher
THIs were found in the CF sample than in the FMF
sample, according to the higher prevalence of FMF
compared with CF in Lebanon.
Furthermore, in a very recent paper, Ten Kate et al.,
(2010) showed a positive correlation between (C0comp-
het) and q). On the basis of this report we developed an
equation in which THI, the total allelic frequency of the
pathogenic alleles for a given disease (q), and the
inbreeding coefficient (F) are used to infer the popula-
tion prevalence of monogenic autosomal recessive dis-
eases (paper in preparation).
The interesting aspect of this genetic epidemiological
approach is that it makes use of data already existing in all
the diagnostic centers of the Mediterranean Sea basin. In
other words, no investment is required to produce these
laboratory data, which, following the approach just
summarized, will yield a ranking order of the frequencies
of the most frequent among rare monogenic disorders in
each country. The final outcome of this approach will
consist in measurements of the THI and mutational
spectra for every autosomal recessive disorder in each
Mediterranean country.
Therefore, we propose to collect mutation data from the
offspring of consanguineous marriages affected with
different autosomal recessive disorders from different
molecular diagnostic laboratories in all the Mediterranean
countries and in particular from Arab countries. We will
obtain in every population a ranking order according to
the different THIs, the values of which will be inversely
proportional to the frequency of the disorder. This
approach will have the advantage over traditional
descriptive epidemiology studies to generate an unbiased
estimate of the relative frequency of the different
autosomal recessive disorders and will be particularly
useful in the Arab world where the rates of consangui-
neous marriages are generally high. Moreover, this
approach will not need the collection of additional
mutation data from the general population because it
has its own built-in population control represented by the
value of C0comp-het. Finally, from a decision-making
point of view, this new combined approach of molecular
and genetic epidemiology based on consanguinity should
become useful (not only in the Arab world) to assess the
opportunity of widespread genetic screening for certain
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autosomal recessive disorders with respect to others
because their relative incidences will help in establishing
priorities for genetic testing at the population level.
This approach based on mutation analysis in offspring of
consanguineous parents can be integrated and supported
by the locus specific databases (LSDBs), which have
been rapidly increasing in number during the last decade
(Romeo, 2010; van Baal et al., 2010). Several national
mutation databases for different Mediterranean popula-
tions, such as the Greek, Cypriot, Iranian, Lebanese,
Israeli, Egyptian, etc. describe mutations of particular
genes (for example, the globin variants and thalassemia
mutations) and contain up to 50% unpublished variations
with, usually, thorough phenotypic descriptions. Everyone
practicing genetic counseling will agree that LSDBs are
useful tools contributing toward the identification of
disease-causing mutations, providing information about
phenotypic patterns associated with a specific mutation
and enabling researchers to define an optimal strategy for
mutation detection. This explains the recent rapid
growth in the number of LSDBs, now available for
hundreds to thousands of human genes (sometimes with
more than one database per gene).
Starting from the experience developed in the last decade,
the performances of 1188 LSDBs was analyzed by Patrinos
et al. (2010) for the presence or absence of 44 content
criteria related to database features. This analysis led the
authors to the conclusion that at present there is less data-
content heterogeneity compared with 8 years ago when a
similar analysis was performed (Claustres et al., 2002).
However, the next relevant question is: how useful are
the LSDBs for helping clinical genetic services in making
a diagnosis? The answer from Patrinos et al. (2010) to this
question is not equally encouraging as they state that
‘current LSDBs do not support data retrieval and transmission
between scientific personnel and clinicians working in diagnostic
laboratories’. Their analysis pinpoints a number of
deficiencies (namely, lack of detailed disease and
phenotypic descriptions for each genetic variant, etc.),
which, if addressed, would allow LSDBs to better serve
the clinical genetics community, patients, their families,
and related associations and not just researchers. They
therefore propose the concept of Clinical Genetics
databases (CGDBs) and the development of a federation
of network of LSDBs and CGDBs that would bridge the
division between gene-centric and genome-wide ap-
proaches to databasing variation. This work should be
promoted and encouraged first at the national level. In
this sense, the Israeli National/Ethnic mutation database
(http://www.goldenhelix.org/server/israeli/) is already a good
model of the enhanced possibilities that other existing
national LSDBs might have in providing useful informa-
tion to genetic services in their own country. In contrast,
the integration of tools for mutation analysis envisaged
by Patrinos et al. (2010) may become one of the main
goals of new international projects aiming at collaborative
genomics for human health, as recently proposed by a
group of medical geneticists from the Mediterranean
region.
The future approaches based on genome
sequencing of Mediterranean population
samples
A recent commentary (Ozcelik et al., 2010) suggests that
‘sequencing a sufficient number of representative Mediterranean
individuals will provide a reference and scaffold for further
genetic studies in the region. Since DNA sequencing technology has
advanced dramatically leading to drastic reductions in cost as well
as profound improvements in efficiency over the last decade, many
sequencing centers are now operational in the world including those
in the Mediterranean sea basin where this capacity could be
further developed and exploited to contribute to the understanding
of human genetic variation in a collaborative fashion’.
On the basis on these considerations, the authors propose
to find an international collaborative Center of Excellence
for Genomics Research in the Mediterranean region. They
suggest that this Center of Excellence ‘be decentralized and
function as a network of researchers and genomics research centers
whose primary remit would be to support and facilitate joint
research proposals. Members of the Center would include scientists
from the region and those supporting development of genomics in the
region. They would engage in projects centered in Mediterranean
laboratories whenever possible and involving transfer of training
and technology to make the Mediterranean focus increasingly
realistic with time. There is much greater strength in using resources
to support science than in creating a new institution. Such a model
would alleviate hurdles of bureaucracy and facilitate transnational
decision-making processes. The funding programs of trans- or
supra-national organizations, such as the European Commission
Framework Programs, World Health Organization, International
Centre for Genetic Engineering and Biotechnology and United
Nations Development Fund serve as excellent models for the
advancement of science and technology, and their dissemination into
society. In parallel with the operational conduct of these
transnational programs, national funding agencies (y.) could
serve as partners. These public Institutions as well as private
companies will have very good scientific reasons to facilitate the
generation of whole genome sequence data on representative
Mediterranean populations, and gene discovery and characteriza-
tion based on well-defined phenotypes in large kindreds and/or
consanguineous families. A wide range of human traits, both rare
and common, could be evaluated. These funding schemes and
scientific objectives are excellent models and realistic goals for
collaborative genomics for human health and cooperation in the
Mediterranean basin, and can have major impact on public health’.
Finally, to enable free and open access to the collected
data, the authors propose that ‘a virtual database named
Genotheca Mediterranea could be established, with its main
location within a historically important institution such as
Bibliotheca Alexandrina (in Alexandria, Egypt) and with mirror
sites in partner countries’. The idea of a Genotheca
Mediterranea is very much in keeping with the federation
of network of LSDBs and CGDBs independently
proposed by Patrinos et al. (2010).
All these ambitious goals can be achieved if geneticists
from the southern and northern rims of the Mediterranean
sea basin decide to work together for a common
endeavour, namely, that of creating the virtual interna-
tional collaborative Center of Excellence for Genomic
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Research in the Mediterranean, focused on consanguinity
studies. The many advantages of this idea are best
understood by reading the Editorial (2010) accompanying
the above Commentary, which underlines that ‘the main
organizational element of this Center is the pair wise collaboration
between investigators within the region, a structure that sets it
apart from most existing research institutions. Partners outside the
region would be welcomed into these collaborations, provided the
emphasis was on building local capacity. Such a bottom-up
approach takes advantage of the funding available to each country,
while at the same time requiring only a relatively small central
council to achieve agreement on aims such as the provision of genetic
tests, operating procedures and priorities for centrally used
resources such as benchmark genomes and databases. With this
setup, Mediterranean geneticists would be able to utilize EU, US,
and other initiatives and accept new investment with minimal
disruption or duplication of local effort’.
The Nature Genetics Editorial concludes that ‘this proposal
is an achievable and pragmatic way to boost research productivity
and improve health outcomes. Geneticists’ commitment to helping
families living with genetic disorders is the motive behind this
initiative, and the research geneticists perform is rooted in identifying
disease-causing mutations, a problem they understand how to solve.
The Mediterranean region is the right frame within which similar
problems can be addressed and within which results can be returned
locally. The proposal is efficient in that it brings together population-
rich and resource-rich countries. Beyond these aspects, there may be
game-changing benefits to understanding our common genetic history
and overcoming common obstacles to health and progress, but
ultimately the aim here is practical rather than political’.
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